Drug
Vamikibart clinical trials
Also written RO7200220.
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2021 | 2 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Hoffmann-La Roche (4) · Eleven Biotherapeutics (1)
Studies
Open first, then newest update. How each study uses vamikibart is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular EdemaCompletedPhase 2Hoffmann-La RocheNCT05151731Written as Vamikibart
- Vamikibart in Participants With Uveitic Macular EdemaCompletedPhase 3Hoffmann-La RocheNCT05642325Written as Vamikibart
- A Study to Investigate Vamikibart in Participants With Uveitic Macular EdemaCompletedPhase 3Hoffmann-La RocheNCT05642312Written as Vamikibart
- A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular EdemaCompletedPhase 2Hoffmann-La RocheNCT05151744Written as Vamikibart
- Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular EdemaWithdrawnPhase 1Eleven BiotherapeuticsNCT02842541Written as EBI-031
Given in every arm · 1 — vamikibart is usual care beside what is tested
Codes
What other systems call vamikibart · ClinicalTrials.gg INT017084
- UNII (FDA) KP04MH1JTTVAMIKIBARTOne source FDA
- NCI Thesaurus C199126VamikibartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KP04MH1JTT | VAMIKIBART | One source FDA |
| NCI Thesaurus | C199126 | Vamikibart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.